Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the recipient of a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 33,300 shares, a decline of 14.4% from the August 31st total of 38,900 shares. Based on an average daily volume of 1,500 shares, the days-to-cover ratio is currently 22.2 days.
Mayne Pharma Group Stock Performance
MAYNF stock opened at $0.18 on Friday. Mayne Pharma Group has a 1-year low of $0.15 and a 1-year high of $0.29. The business has a fifty day moving average price of $0.22 and a 200-day moving average price of $0.20.
Get Mayne Pharma Group alerts:About Mayne Pharma Group
(Get Rating)
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, the United States, Asia, and internationally. The company operates through four segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International.Further Reading
- Get a free copy of the StockNews.com research report on Mayne Pharma Group (MAYNF)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Let Paychex Stock Work Hard For You
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.